ESS is currently being developed with support from
Post# of 30028
Posted On: 11/17/2014 4:08:49 PM
ESS is currently being developed with support from a grant from the Armed Forces Institute for Regenerative Medicine (AFIRM). The AFIRM grant was awarded to support the IND and initial clinical studies. Upon execution of its option, Amarantus anticipates initiating a10 patient, Phase 1/2a clinical study, evaluating the efficacy of ESS vs. meshed split thickness autograft (AG) in the second quarter of 2015
(0)
(0)Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼